Page last updated: 2024-11-02

pentoxifylline and Cardiomyopathy, Chagas

pentoxifylline has been researched along with Cardiomyopathy, Chagas in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Silva Grijó Farani, P1
Iandra da Silva Ferreira, B1
Begum, K1
Vilar-Pereira, G2
Pereira, IR2
Fernández-Figueroa, EA1
Cardenas-Ovando, RA1
Almeida, IC1
Roy, S1
Lannes-Vieira, J2
Moreira, OC2
Ramos, IP1
Gibaldi, D1
Britto, C1
Moraes, MO1

Other Studies

2 other studies available for pentoxifylline and Cardiomyopathy, Chagas

ArticleYear
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
    PLoS neglected tropical diseases, 2023, Volume: 17, Issue:3

    Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Fibrosis; Gene Expression Pr

2023
Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response.
    PLoS neglected tropical diseases, 2015, Volume: 9, Issue:3

    Topics: Animals; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Connexin 43; Heart; Interferon-gamma; Mi

2015